Effects of radium-223 dichloride (Ra-223) with docetaxel (D) vs D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Memorial Sloan Kettering Cancer Center, Seattle Cancer Care Alliance, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Endeavor Health, Evanston Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Université Paris-Sud, Institut Gustave Roussy, Bayer (United States), Bayer (Norway)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4246702383